Metabolic phenotypes of cancer cells are heterogeneous and flexible as a tumor mass is a hurriedly evolving system capable of constant adaptation to oxygen and nutrient availability. The exact type of cancer metabolism arises from the combined effects of factors intrinsic to the cancer cells and factors proposed by the tumor microenvironment. As a result, a condition termed oncogenic metabolic symbiosis in which components of the tumor microenvironment (TME) promote tumor growth often occurs. Understanding how oncogenic metabolic symbiosis emerges and evolves is crucial for perceiving tumorigenesis. The process by which tumor cells reprogram their TME involves many mechanisms, including changes in intercellular communication, alterations in metabolic phenotypes of TME cells, and rearrangement of the extracellular matrix. It is possible that one molecule with a pleiotropic effect such as Caveolin-1 may affect many of these pathways. Here, we discuss the significance of Caveolin-1 in establishing metabolic symbiosis in TME.

BIOCEV 1st Faculty of Medicine Charles University Vestec Czech Republic

Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech Republic

Department of Pathological Physiology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Physiology Faculty of Medicine Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab 2016;23:27-47.

Lyssiotis CA, Kimmelman AC. Metabolic interactions in the tumor microenvironment. Trends Cell Biol 2017;27:863-75.

Mangia S, Simpson IA, Vannucci SJ, et al. The in vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation. J Neurochem 2009;109:55-62.

Nishiyama K, Trapp BD, Ikezu T, et al. Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease. J Neurosci 1999;19:6538-48.

Song KS, Scherer PE, Tang Z, et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996;271:15160-5.

Li WP, Liu P, Pilcher BK, et al. Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J Cell Sci 2001;114(Pt 7):1397-408.

Parolini I, Sargiacomo M, Galbiati F, et al. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. J Biol Chem 1999;274:25718-25.

Sargiacomo M, Scherer PE, Tang Z, et al. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci USA 1995;92:9407-11.

Das K, Lewis RY, Scherer PE, et al. The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo. J Biol Chem 1999;274:18721-8.

Fiala GJ, Minguet S. Chapter 3-Caveolin-1: the unnoticed player in TCR and BCR signaling. In: Alt F, ed. Advances in immunology. Cambridge, MA: Academic Press, 2018. 83-133.

Pol A, Martin S, Fernandez MA, et al. Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies. Mol Biol Cell 2005;16:2091-105.

Khater IM, Aroca-Ouellette ST, Meng F, et al. Caveolae and scaffold detection from single molecule localization microscopy data using deep learning. PLoS One 2019;14:e0211659.

Khater IM, Liu Q, Chou KC, et al. Super-resolution modularity analysis shows polyhedral caveolin-1 oligomers combine to form scaffolds and caveolae. Sci Rep 2019;9:9888.

Lajoie P, Goetz JG, Dennis JW, et al. Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J Cell Biol 2009;185:381-5.

Cheng JPX, Mendoza-Topaz C, Howard G, et al. Caveolae protect endothelial cells from membrane rupture during increased cardiac output. J Cell Biol 2015;211:53-61.

Lo HP, Nixon SJ, Hall TE, et al. The caveolin-cavin system plays a conserved and critical role in mechanoprotection of skeletal muscle. J Cell Biol 2015;210:833-49.

Machleidt T, Li W-P, Liu P, et al. Multiple domains in caveolin-1 control its intracellular traffic. J Cell Biol 2000;148:17-28.

Schlegel A, Lisanti MP. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. J Biol Chem 2000;275:21605-17.

Parton RG, Hanzal-Bayer M, Hancock JF. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J Cell Sci 2006;119:787.

Nomura R, Fujimoto T. Tyrosine-phosphorylated caveolin-1: immunolocalization and molecular characterization. Mol Biol Cell 1999;10:975-86.

Sanguinetti AR, Mastick CC. c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14. Cell Signal 2003;15:289-98.

Sanguinetti A, Cao H, Mastick C. Fyn is required for oxidative- and hyperosmotic-stress-induced tyrosine phosphorylation of caveolin-1. Biochem J 2003;376:159-68.

Hau AM, Gupta S, Leivo MZ, et al. Dynamic regulation of caveolin-1 phosphorylation and caveolae formation by mammalian target of rapamycin complex 2 in bladder cancer cells. Am J Pathol 2019;189:1846-62.

Orlichenko L, Huang B, Krueger E, et al. Epithelial growth factor-induced phosphorylation of caveolin 1 at tyrosine 14 stimulates caveolae formation in epithelial cells. J Biol Chem 2006;281:4570-9.

Wehinger S, Ortiz R, Díaz MI, et al. Phosphorylation of caveolin-1 on tyrosine-14 induced by ROS enhances palmitate-induced death of beta-pancreatic cells. Biochim Biophys Acta 2015;1852:693-708.

Zimnicka AM, Husain YS, Shajahan AN, et al. Src-dependent phosphorylation of caveolin-1 Tyr-14 promotes swelling and release of caveolae. Mol Biol Cell 2016;27:2090-106.

Sverdlov M, Shinin V, Place AT, et al. Filamin a regulates caveolae internalization and trafficking in endothelial cells. Mol Biol Cell 2009;20:4531-40.

Joshi B, Bastiani M, Strugnell SS, et al. Phosphocaveolin-1 is a mechanotransducer that induces caveola biogenesis via Egr1 transcriptional regulation. J Cell Biol 2012;199:425-35.

Patel HH, Murray F, Insel PA. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 2008;48:359-91.

Liu P, Rudick M, Anderson RG. Multiple functions of caveolin-1. J Biol Chem 2002;277:41295-8.

Jung W, Sierecki E, Bastiani M, et al. Cell-free formation and interactome analysis of caveolae. J Cell Biol 2018;217:2141-65.

Bernatchez PN, Bauer PM, Yu J, et al. Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proc Natl Acad Sci USA 2005;102:761-6.

Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Caveolae and signalling in cancer. Nat Rev Cancer 2015;15:225.

Garcia-Cardena G, Fan R, Stern DF, et al. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem 1996;271:27237-40.

Kraehling JR, Hao Z, Lee MY, et al. Uncoupling caveolae from intracellular signaling in vivo. Circ Res 2016;118:48-55.

Williams TM, Lisanti MP. The caveolin proteins. Genome Biol 2004;5:214.

Cohen AW, Hnasko R, Schubert W, et al. Role of caveolae and caveolins in health and disease. Physiol Rev 2004;84:1341-79.

Gilbert G, Ducret T, Savineau JP, et al. Caveolae are involved in mechanotransduction during pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2016;310:L1078-87.

Sinha B, Köster D, Ruez R, et al. Cells respond to mechanical stress by rapid disassembly of caveolae. Cell 2011;144:402-13.

Navarro A, Anand-Apte B, Parat MO. A role for caveolae in cell migration. FASEB J 2004;18:1801-11.

Conrad PA, Smart EJ, Ying YS, et al. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. J Cell Biol 1995;131(6 Pt 1):1421-33.

Schlegel A, Arvan P, Lisanti MP. Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum. J Biol Chem 2001;276:4398-408.

Chretien A, Piront N, Delaive E, et al. Increased abundance of cytoplasmic and nuclear caveolin 1 in human diploid fibroblasts in H2O2-induced premature senescence and interplay with p38alpha(MAPK). FEBS Lett 2008;582:1685-92.

Shi Y, Tan S-H, Ng S, et al. Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy. Autophagy 2015;11:769-84.

Woudenberg J, Rembacz KP, van den Heuvel FA, et al. Caveolin-1 is enriched in the peroxisomal membrane of rat hepatocytes. Hepatology 2010;51:1744-53.

Tagawa A, Mezzacasa A, Hayer A, et al. Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. J Cell Biol 2005;170:769-79.

Campos A, Salomon C, Bustos R, et al. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines. Nanomedicine (Lond) 2018;13:2597-609.

Lee H, Li C, Zhang Y, et al. Caveolin-1 selectively regulates microRNA sorting into microvesicles after noxious stimuli. J Exp Med 2019;216:2202-20.

Ostermeyer AG, Paci JM, Zeng Y, et al. Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets. J Cell Biol 2001;152:1071-8.

Shu SL, Yang Y, Allen CL, et al. Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 2018;8:12905.

Zhang L, Zhang S, Yao J, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 2015;527:100-4.

Logozzi M, Milito A, Lugini L, et al. High levels of exosomes expressing CD63 and Caveolin-1 in plasma of melanoma patients. PLoS One 2009;4:e5219.

Llorente A, de Marco MC, Alonso MA. Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line. J Cell Sci 2004;117:5343-51.

Sawada N, Taketani Y, Amizuka N, et al. Caveolin-1 in extracellular matrix vesicles secreted from osteoblasts. Bone 2007;41:52-8.

Crewe C, Joffin N, Rutkowski JM, et al. An endothelial-to-adipocyte extracellular vesicle axis governed by metabolic state. Cell 2018;175:695-708.e13.

Yu D-M, Jung SH, An H-T, et al. Caveolin-1 deficiency induces premature senescence with mitochondrial dysfunction. Aging Cell 2017;16:773-84.

Schilling JM, Dhanani M, Haushalter KJ, et al. Loss of caveolin-1 alters cardiac mitochondrial function and increases susceptibility to stress. J Mol Cell Cardiol 2017;112:165.

Volonte D, Liu Z, Shiva S, et al. Caveolin-1 controls mitochondrial function through regulation of m-AAA mitochondrial protease. Aging 2016;8:2355-69.

Fernandez-Rojo MA, Restall C, Ferguson C, et al. Caveolin-1 orchestrates the balance between glucose and lipid-dependent energy metabolism: implications for liver regeneration. Hepatology 2012;55:1574-84.

Cohen AW, Razani B, Schubert W, et al. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 2004;53:1261-70.

Kuo A, Lee MY, Yang K, et al. Caveolin-1 regulates lipid droplet metabolism in endothelial cells via autocrine prostacyclin-stimulated, cAMP-mediated lipolysis. J Biol Chem 2018;293:973-83.

Fridolfsson H, Kawaraguchi Y, Ali S, et al. Mitochondria-localized caveolin in adaptation to cellular stress and injury. FASEB J 2012;26:4637-49.

Bosch M, Mari M, Herms A, et al. Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. Curr Biol 2011;21:681-6.

Bajzikova M, Kovarova J, Coelho AR, et al. Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient Cancer cells. Cell Metab 2019;29:399-416.e10.

Berridge MV, Tan AS. Effects of mitochondrial gene deletion on tumorigenicity of metastatic melanoma: reassessing the Warburg effect. Rejuvenation Res 2010;13:139-41.

Curry JM, Tuluc M, Whitaker-Menezes D, et al. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle 2013;12:1371-84.

Tabassum DP, Polyak K. Tumorigenesis: it takes a village. Nat Rev Cancer 2015;15:473.

Feron O. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 2009;92:329-33.

Sonveaux P, Végran F, Schroeder T, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008;118:3930-42.

Varela-Guruceaga M, Milagro FI, Martínez JA, et al. Effect of hypoxia on caveolae-related protein expression and insulin signaling in adipocytes. Mol Cell Endocrinol 2018;473:257-67.

Hui S, Ghergurovich JM, Morscher RJ, et al. Glucose feeds the TCA cycle via circulating lactate. Nature 2017;551:115-8.

Boidot R, Vegran F, Meulle A, et al. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer Res 2012;72:939-48.

Quanz M, Bender E, Kopitz C, et al. Preclinical efficacy of the novel monocarboxylate transporter 1 inhibitor BAY-8002 and associated markers of resistance. Mol Cancer Ther 2018;17:2285.

Johnson JM, Cotzia P, Fratamico R, et al. MCT1 in invasive ductal carcinoma: monocarboxylate metabolism and aggressive breast cancer. Front Cell Dev Biol 2017;5:27.

Park S, Chang CY, Safi R, et al. ERRalpha-regulated lactate metabolism contributes to resistance to targeted therapies in breast cancer. Cell Rep 2016;15:323-35.

Christie CF, Fang D, Hunt EG, et al. Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content. FASEB J 2019;33:8186-201.

Urbano F, Bugliani M, Filippello A, et al. Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat beta-cells. Direct Effect of Oxidative Stress. Sci Rep 2017;7:11863.

Pelat M, Dessy C, Massion P, et al. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E−/− mice in vivo. Circulation 2003;107:2480-6.

Brouet A, Sonveaux P, Dessy C, et al. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res 2001;89:866-73.

Longster AL, MacDougall DA, Porter KE, et al. In vivo simvastatin treatment differentially affects Caveolin-1 and Caveolin-3 expression in the adult rat myocardium. Biophys J 2012;102:138.

Mausner-Fainberg K, Luboshits G, Mor A, et al. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis 2008;197:829-39.

Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006;12:178-80.

Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999;163:5211-8.

Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000;348(Pt 3):607-14.

Zhuang Y, Chan DK, Haugrud AB, et al. Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivo. PLoS One 2014;9:e108444.

Galbiati F, Volonte D, Liu J, et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 2001;12:2229-44.

Hulit J, Bash T, Fu M, et al. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J Biol Chem 2000;275:21203-9.

Torres VA, Tapia JC, Rodriguez DA, et al. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein surviving via reduced beta-catenin-Tcf/Lef-dependent transcription. Mol Cell Biol 2007;27:7703-17.

Galbiati F, Volonte D, Engelman JA, et al. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 1998;17:6633-48.

Volonte D, Vyas AR, Chen C, et al. Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence. J Biol Chem 2018;293:1794-809.

Bartholomew JN, Volonte D, Galbiati F. Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway. Cancer Res 2009;69:2878-86.

Koleske AJ, Baltimore D, Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 1995;92:1381-5.

Cerezo A, Guadamillas MC, Goetz JG, et al. The absence of caveolin-1 increases proliferation and anchorage-independent growth by a Rac-dependent, Erk-independent mechanism. Mol Cell Biol 2009;29:5046-59.

Wang Z, Wang N, Li W, et al. Caveolin-1 mediates chemoresistance in breast cancer stem cells via beta-catenin/ABCG2 signaling pathway. Carcinogenesis 2014;35:2346-56.

Ho CC, Huang PH, Huang HY, et al. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol 2002;161:1647-56.

Ravid D, Maor S, Werner H, et al. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene 2005;24:1338-47.

Joshi B, Strugnell SS, Goetz JG, et al. Phosphorylated caveolin-1 regulates rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res 2008;68:8210-20.

Ko YG, Liu P, Pathak RK, et al. Early effects of pp60(v-src) kinase activation on caveolae. J Cell Biochem 1998;71:524-35.

Parton RG, del Pozo MA. Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 2013;14:98-112.

Torrino S, Shen W-W, Blouin CM, et al. EHD2 is a mechanotransducer connecting caveolae dynamics with gene transcription. J Cell Biol 2018;217:4092-105.

Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008;68:3645-54.

Petrova YI, Schecterson L, Gumbiner BM. Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell 2016;27:3233-44.

Moon H, Lee CS, Inder KL, et al. PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer. Oncogene 2014;33:3561-70.

Borza CM, Chen X, Mathew S, et al. Integrin {alpha}1{beta}1 promotes caveolin-1 dephosphorylation by activating T cell protein-tyrosine phosphatase. J Biol Chem 2010;285:40114-24.

Radel C, Rizzo V. Integrin mechanotransduction stimulates caveolin-1 phosphorylation and recruitment of Csk to mediate actin reorganization. Am J Physiol Heart Circ Physiol 2005;288:H936-45.

Park JH, Ryu JM, Han HJ. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways. J Cell Physiol 2011;226:267-75.

Quest AFG, Gutierrez-Pajares JL, Torres VA. Caveolin-1: an ambiguous partner in cell signalling and cancer. J Cell Mol Med 2008;12:1130-50.

Feldman R, Gatalica Z, Reddy SK, et al. Caveolin-1: oncogenic role in breast cancer? Clues from molecular profiling. J Clin Oncol 2015;33(28_suppl):134.

Wang S, Wang N, Zheng Y, et al. Caveolin-1: an oxidative stress-related target for cancer prevention. Oxid Med Cell Longev 2017;2017:7454031.

Deb M, Sengupta D, Kar S, et al. Elucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulators. Tumor Biol 2014;35:12031-47.

Shatz M, Liscovitch M. Caveolin-1: a tumor-promoting role in human cancer. Int J Radiat Biol 2008;84:177-89.

Wang X, Peralta S, Moraes CT. Chapter 4-Mitochondrial alterations during carcinogenesis: a review of metabolic transformation and targets for anticancer treatments. In: Tew KD, Fisher PB, eds Advances in Cancer Research. Cambridge, MA: Academic Press, 2013. 127-60.

Wang Z, Wang N, Liu P, et al. Caveolin-1, a stress-related oncotarget, in drug resistance. Oncotarget 2015;6:37135-50.

Bainbridge P. Wound healing and the role of fibroblasts. J Wound Care 2013;22:407-8. 10-12.

Madar S, Goldstein I, Rotter V. 'Cancer associated fibroblasts'-more than meets the eye. Trends Mol Med 2013;19:447-53.

Arcucci A, Ruocco MR, Amatruda N, et al. Analysis of extracellular superoxide dismutase in fibroblasts from patients with systemic sclerosis. J Biol Regul Homeost Agents 2011;25:647-54.

Shihata WA, Putra MRA, Chin-Dusting JPF. Is there a potential therapeutic role for Caveolin-1 in fibrosis? Front Pharmacol 2017;8:567.

Dimmer KS, Friedrich B, Lang F, et al. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J 2000;350(Pt 1):219-27.

Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, et al. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle 2010;9:1960-71.

Wu KN, Queenan M, Brody JR, et al. Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival. Cell Cycle 2011;10:4250-5.

Zhao Z, Han F-H, Yang S-B, et al. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival. World J Gastroenterol 2015;21:1140-7.

Witkiewicz AK, Whitaker-Menezes D, Dasgupta A, et al. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Cell Cycle 2012;11:1108-17.

Di Vizio D, Morello M, Sotgia F, et al. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 2009;8:2420-4.

Chiavarina B, Whitaker-Menezes D, Migneco G, et al. HIF1-alpha functions as a tumor promoter in cancer-associated fibroblasts, and as a tumor suppressor in breast cancer cells. Cell Cycle 2010;9:3534-51.

Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010;9:3256-76.

Tassone P, Domingo-Vidal M, Whitaker-Menezes D, et al. Metformin effects on metabolic coupling and tumor growth in oral cavity squamous cell carcinoma coinjection xenografts. Otolaryngol Head Neck Surg 2017;158:867-77.

Ning X, Du Y, Ben Q, et al. Bulk pancreatic cancer cells can convert into cancer stem cells (CSCs) in vitro and 2 compounds can target these CSCs. Cell Cycle 2016;15:403-12.

Hirsch HA, Iliopoulos D, Tsichlis PN, et al. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 2009;69:7507-11.

Farnie G, Sotgia F, Lisanti MP. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Oncotarget 2015;6:30472-86.

Janiszewska M, Suva ML, Riggi N, et al. Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev 2012;26:1926-44.

Lea MA, Chacko J, Bolikal S, et al. Addition of 2-deoxyglucose enhances growth inhibition but reverses acidification in colon cancer cells treated with phenformin. Anticancer Res 2011;31:421-6.

Curry J, Johnson J, Tassone P, et al. Metformin effects on head and neck squamous carcinoma microenvironment: window of opportunity trial. Laryngoscope 2017;127:1808-15.

Rohlenova K, Sachaphibulkij K, Stursa J, et al. Selective disruption of respiratory supercomplexes as a New strategy to suppress Her2(high) breast cancer. Antioxid Redox Signal 2017;26:84-103.

Krejcir R, Krcova L, Zatloukalova P, et al. A cyclic pentamethinium salt induces cancer cell cytotoxicity through mitochondrial disintegration and metabolic collapse. Int J Mol Sci 2019;20:4208.

Kumar D, New J, Vishwakarma V, et al. Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression. Cancer Res 2018;78:3769-82.

Goetz JG, Minguet S, Navarro-Lérida I, et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 2011;146:148-63.

Santilman V, Baran J, Parat M-O. Binding to intermediate filaments is required for caveolin-1 polarization in transmigrating cells. Cancer Res 2007;67:2994.

Jiu Y. Vimentin intermediate filaments function as a physical barrier during intracellular trafficking of caveolin-1. Biochem Biophys Res Commun 2018;507:161-7.

Moreno-Vicente R, Pavon DM, Martin-Padura I, et al. Caveolin-1 modulates mechanotransduction responses to substrate stiffness through actin-dependent control of YAP. Cell Rep 2018;25:1622-35.e6.

Nurmik M, Ullmann P, Rodriguez F, et al. In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer 2020;146:895-905.

Penkert J, Ripperger T, Schieck M, et al. On metabolic reprogramming and tumor biology: a comprehensive survey of metabolism in breast cancer. Oncotarget 2016;7:67626-49.

Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov 2018;17:887-904.

Goossens P, Rodriguez-Vita J, Etzerodt A, et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab 2019;29:1376-89.e4.

Halbrook CJ, Pontious C, Kovalenko I, et al. Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer. Cell Metab 2019;29:1390-9.e6.

Miwa H, Fujii J, Kanno H, et al. Pyruvate secreted by human lymphoid cell lines protects cells from hydrogen peroxide mediated cell death. Free Radic Res 2000;33:45-56.

Khiati S, Dalla Rosa I, Sourbier C, et al. Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity. Clin Cancer Res 2014;20:4873-81.

Heller S, Schubert S, Krehan M, et al. Efficient repopulation of genetically derived rho zero cells with exogenous mitochondria. PLoS One 2013;8:e73207.

Xue J, Schmidt SV, Sander J, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014;40:274-88.

Biswas SK, Allavena P, Mantovani A. Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin Immunopathol 2013;35:585-600.

Lindsten T, Hedbrant A, Ramberg A, et al. Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2. Int J Oncol 2017;51:104-14.

Celus W, Di Conza G, Oliveira AI, et al. Loss of Caveolin-1 in metastasis-associated macrophages drives lung metastatic growth through increased angiogenesis. Cell Rep 2017;21:2842-54.

Ip WKE, Hoshi N, Shouval DS, et al. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science (New York, NY) 2017;356:513-9.

Feng J, Li L, Ou Z, et al. IL-25 stimulates M2 macrophage polarization and thereby promotes mitochondrial respiratory capacity and lipolysis in adipose tissues against obesity. Cell Mol Immunol 2018;15:493-505.

Vats D, Mukundan L, Odegaard JI, et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 2006;4:13-24.

Tan Z, Xie N, Banerjee S, et al. The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages. J Biol Chem 2015;290:46-55.

Liu D, Chang C, Lu N, et al. Comprehensive proteomics analysis reveals metabolic reprogramming of tumor-associated macrophages stimulated by the tumor microenvironment. J Proteome Res 2017;16:288-97.

Arts RJ, Plantinga TS, Tuit S, et al. Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages. Onco Targets Ther 2016;5:e1229725.

Penny HL, Sieow JL, Adriani G, et al. Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma. Onco Targets Ther 2016;5:e1191731.

Corzo CA, Condamine T, Lu L, et al. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 2010;207:2439-53.

Burke B, Giannoudis A, Corke KP, et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 2003;163:1233-43.

Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003;112:645-57.

Kelly B, O'Neill LAJ. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res 2015;25:771-84.

Peyssonnaux C, Datta V, Cramer T, et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005;115:1806-15.

Ohashi T, Akazawa T, Aoki M, et al. Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity. Int J Cancer 2013;133:1107-18.

Colegio OR, Chu NQ, Szabo AL, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 2014;513:559-63.

Arlauckas SP, Garren SB, Garris CS, et al. Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages. Theranostics 2018;8:5842-54.

MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-50.

Brouet A, DeWever J, Martinive P, et al. Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide. FASEB J 2005;19:602-4.

Wang XM, Kim HP, Song R, et al. Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. Am J Respir Cell Mol Biol 2006;34:434-42.

Auriac A, Willemetz A, Canonne-Hergaux F. Lipid raft-dependent endocytosis: a new route for hepcidin-mediated regulation of ferroportin in macrophages. Haematologica 2010;95:1269-77.

Cairo G, Recalcati S, Mantovani A, et al. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol 2011;32:241-7.

Kubala MH, Punj V, Placencio-Hickok VR, et al. Plasminogen activator inhibitor-1 promotes the recruitment and polarization of macrophages in cancer. Cell Rep 2018;25:2177-91.e7.

Humphries BA, Buschhaus JM, Chen YC, et al. Plasminogen activator inhibitor 1 (PAI1) promotes actin cytoskeleton reorganization and glycolytic metabolism in triple-negative breast cancer. Mol Cancer Res 2019;17:1142-54.

Viola A, Munari F, Sánchez-Rodríguez R, et al. The metabolic signature of macrophage responses. Front Immunol 2019;10:1462.

Soukupova J, Malfettone A, Hyroššová P, et al. Role of the transforming growth factor-β in regulating hepatocellular carcinoma oxidative metabolism. Sci Rep 2017;7:12486.

DeBerardinis RJ, Mancuso A, Daikhin E, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 2007;104:19345-50.

Palmieri EM, Menga A, Martin-Perez R, et al. Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis. Cell Rep 2017;20:1654-66.

Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010;35:427-33.

Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-96.

Maeda S, Kamata H, Luo JL, et al. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005;121:977-90.

Ortiz-Masiá D, Cosín-Roger J, Calatayud S, et al. M1 macrophages activate the notch signalling in epithelial cells: relevance in Crohn's disease. J Crohns Colitis 2016;10:582-92.

Venkatesh V, Nataraj R, Thangaraj GS, et al. Targeting notch signalling pathway of cancer stem cells. Stem Cell Investig 2018;5:5.

Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008;454:436-44.

Wegrzyn J, Potla R, Chwae YJ, et al. Function of mitochondrial Stat3 in cellular respiration. Science (New York, NY) 2009;323:793-7.

Gough DJ, Corlett A, Schlessinger K, et al. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science (New York, NY) 2009;324:1713-6.

Lee M, Hirpara JL, Eu J-Q, et al. Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors. Redox Biol 2018;25:101073.

Szczepanek K, Lesnefsky EJ, Larner AC. Multi-tasking: nuclear transcription factors with novel roles in the mitochondria. Trends Cell Biol 2012;22:429-37.

Wan S, Zhao E, Kryczek I, et al. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology 2014;147:1393-404.

Sansone P, Storci G, Tavolari S, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 2007;117:3988-4002.

Al-Khalili L, Bouzakri K, Glund S, et al. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 2006;20:3364-75.

Mahon KL, Lin HM, Castillo L, et al. Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer. Br J Cancer 2015;112:1340-8.

Quaranta V, Rainer C, Nielsen SR, et al. Macrophage-derived Granulin drives resistance to immune checkpoint inhibition in metastatic pancreatic cancer. Cancer Res 2018;78:4253-69.

Jobe NP, Rosel D, Dvorankova B, et al. Simultaneous blocking of IL-6 and IL-8 is sufficient to fully inhibit CAF-induced human melanoma cell invasiveness. Histochem Cell Biol 2016;146:205-17.

Podar K, Tai YT, Cole CE, et al. Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. J Biol Chem 2003;278:5794-801.

Croucher PI, McDonald MM, Martin TJ. Bone metastasis: the importance of the neighbourhood. Nat Rev Cancer 2016;16:373.

Zhang X, Tachibana S, Wang H, et al. Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice. Hepatology (Baltimore, MD) 2010;52:2137-47.

Lengyel E, Makowski L, DiGiovanni J, et al. Cancer as a matter of fat: the crosstalk between adipose tissue and tumors. Trends Cancer 2018;4:374-84.

Palm W, Thompson CB. Nutrient acquisition strategies of mammalian cells. Nature 2017;546:234-42.

Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogene 2016;5:e189.

Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011;17:1498-503.

Huang CK, Chang PH, Kuo WH, et al. Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via beta-hydroxybutyrate. Nat Commun 2017;8:14706.

Le Lay S, Briand N, Blouin CM, et al. The lipoatrophic caveolin-1 deficient mouse model reveals autophagy in mature adipocytes. Autophagy 2010;6:754-63.

Briand N, Le Lay S, Sessa WC, et al. Distinct roles of endothelial and adipocyte Caveolin-1 in macrophage infiltration and adipose tissue metabolic activity. Diabetes 2011;60:448-53.

Kir S, Spiegelman BM. Cachexia & brown fat: a burning issue in cancer. Trends Cancer 2016;2:461-3.

Petruzzelli M, Schweiger M, Schreiber R, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab 2014;20:433-47.

Kir S, White JP, Kleiner S, et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 2014;513:100-4.

Wu Q, Li J, Li Z, et al. Exosomes from the tumour-adipocyte interplay stimulate beige/brown differentiation and reprogram metabolism in stromal adipocytes to promote tumour progression. J Exp Clin Cancer Res 2019;38:223.

Klingenberg M, Huang S-G. Structure and function of the uncoupling protein from brown adipose tissue. Biochim Biophys Acta Biomembr 1999;1415:271-96.

Cohen AW, Schubert W, Brasaemle DL, et al. Caveolin-1 expression is essential for proper nonshivering thermogenesis in brown adipose tissue. Diabetes 2005;54:679-86.

Mayi TH, Daoudi M, Derudas B, et al. Human adipose tissue macrophages display activation of cancer-related pathways. J Biol Chem 2012;287:21904-13.

Advances in Cancer Metabolism and Tumour Microenvironment